Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
This study is currently recruiting participants.
Verified January 2012 by University of Milan
Sponsor:
University of Milan
Information provided by (Responsible Party):
Gian Vincenzo Zuccotti, University of Milan
ClinicalTrials.gov Identifier:
NCT01512784
First received: January 13, 2012
Last updated: January 18, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |